• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVANCE, INC. ¿ 1725056 ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS; ARCTIC GEL PAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVANCE, INC. ¿ 1725056 ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS; ARCTIC GEL PAD Back to Search Results
Catalog Number 317-07
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/28/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the target temperature management case was started on (b)(6) 2021, for a severe traumatic brain injury (tbi) patient.The patient was treated with normothermia protocol with new medium sized arctic gel pads.On (b)(6) 2021, doctors found that the arctic gel pad layer had peeled away from all 4 gel pads on both legs and chest.The gel pads no longer had the ability to stick to the patient¿s skin, and it needs to be fixed with ties.The gel pads were stored at a room temperature of 20c to 24c in the storage.The gel pads were in good condition, with no signs of gel peeling prior to initiating therapy.The gel pads were not exposed to any liquids during patient care.It was mentioned that the patient temperature was difficult to control.
 
Manufacturer Narrative
The reported event was confirmed.The root cause was unknown.1 sample was confirmed to exhibit the reported failure.The device had not met specifications.The product was used for patient treatment.The product caused the reported failure.Visual evaluation of the returned sample noted one medium arctic gel pad kit with no original packaging present.Visual inspection noted that the hydrogel layer was separated from the pad on the left chest, right chest, left thigh, right thigh on the return sample.A potential failure mode is "3.1 hydrogel peels away from film".A potential root cause for this failure could be "3.1.1 improper design consideration or material selection".The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "the neonatal arcticgel¿ pad is non-sterile for single patient use only.The water content of the hydrogel affects the pad¿s adhesion to the skin and conductivity, and therefore, the efficiency of controlling patient temperature.Periodically check that pads remain moist and adherent.Replace pads when the hydrogel no longer uniformly adheres to the skin.Replacing pads at least every 5 days is recommended".The actual/suspected device was inspected.
 
Event Description
It was reported that the target temperature management case was started on (b)(6) 2021, for a severe traumatic brain injury (tbi) patient.The patient was treated with normothermia protocol with new medium sized arctic gel pads.On (b)(6) 2021, doctors found that the arctic gel pad layer had peeled away from all 4 gel pads on both legs and chest.The gel pads no longer had the ability to stick to the patient¿s skin, and it needs to be fixed with ties.The gel pads were stored at a room temperature of 20c to 24c in the storage.The gel pads were in good condition, with no signs of gel peeling prior to initiating therapy.The gel pads were not exposed to any liquids during patient care.It was mentioned that the patient temperature was difficult to control.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS
Type of Device
ARCTIC GEL PAD
Manufacturer (Section D)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
suite 200
louisville 80027
Manufacturer (Section G)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
suite 200
louisville 80027
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington 30014
7707846100
MDR Report Key13349458
MDR Text Key285410583
Report Number1018233-2022-00164
Device Sequence Number1
Product Code DWJ
Combination Product (y/n)N
Reporter Country CodeVM
PMA/PMN Number
K142702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Catalogue Number317-07
Device Lot NumberNGFS2837
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/20/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/26/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-